Business Context and Reporting Period
Company: Church & Dwight Co., Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 9, 2025
Context: The Company announced a definitive agreement to divest its Vitamin, Minerals, and Supplement (VMS) business segment following a strategic review.
Key Financial Metrics
This filing is a current report regarding a corporate transaction and does not contain periodic financial statements. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
- Asset Divestiture: Entered into a definitive agreement to sell the VitaFusion® and L'il Critters® brands.
- Scope of Sale: The transaction includes related trademarks, licenses, and manufacturing and distribution facilities located in Vancouver and Ridgefield, Washington.
- Transaction Status: The sale is expected to close before the end of the fiscal year, subject to customary closing conditions.
Guidance, Outlook, and Risks
Management Commentary: The sale follows a strategic review of the VMS business. The Company intends to finalize the transaction prior to year-end.
Risks and Contingencies: Closing of the transaction is contingent upon the satisfaction of customary closing conditions. No specific financial guidance or outlook for the remaining business was included in this filing.
Investor Verification Checklist
- Verify the final closing date of the VitaFusion® and L'il Critters® sale to confirm if it occurs before year-end.
- Review the definitive purchase agreement (if filed separately) for specific purchase price and earn-out structures.
- Assess the impact of the divestiture on future revenue streams and segment reporting in upcoming 10-Q or 10-K filings.
- Confirm the status of the manufacturing facilities in Washington state post-transaction.